Rnd3/RhoE Modulates Hypoxia-Inducible Factor 1α/Vascular Endothelial Growth Factor Signaling by Stabilizing Hypoxia-Inducible Factor 1α and Regulates Responsive Cardiac Angiogenesis

Xiaojing Yue, Xi Lin, Tingli Yang, Xiangsheng Yang, Xin Yi, Xuejun Jiang, Xiaoyan Li, Tianfa Li, Junli Guo, Yuan Dai, Jianjian Shi, Lei Wei, Keith A. Youker, Guillermo Torre-Amione, Yanhong Yu, Kelsey C. Andrade, Jiang Chang

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The insufficiency of compensatory angiogenesis in the heart of patients with hypertension contributes to heart failure transition. The hypoxia-inducible factor 1α-vascular endothelial growth factor (HIF1α-VEGF) signaling cascade controls responsive angiogenesis. One of the challenges in reprograming the insufficient angiogenesis is to achieve a sustainable tissue exposure to the proangiogenic factors, such as HIF1α stabilization. In this study, we identified Rnd3, a small Rho GTPase, as a proangiogenic factor participating in the regulation of the HIF1α-VEGF signaling cascade. Rnd3 physically interacted with and stabilized HIF1α, and consequently promoted VEGFA expression and endothelial cell tube formation. To demonstrate this proangiogenic role of Rnd3 in vivo, we generated Rnd3 knockout mice. Rnd3 haploinsufficient (Rnd3+/-) mice were viable, yet developed dilated cardiomyopathy with heart failure after transverse aortic constriction stress. The poststress Rnd3+/- hearts showed significantly impaired angiogenesis and decreased HIF1α and VEGFA expression. The angiogenesis defect and heart failure phenotype were partially rescued by cobalt chloride treatment, a HIF1α stabilizer, confirming a critical role of Rnd3 in stress-responsive angiogenesis. Furthermore, we generated Rnd3 transgenic mice and demonstrated that Rnd3 overexpression in heart had a cardioprotective effect through reserved cardiac function and preserved responsive angiogenesis after pressure overload. Finally, we assessed the expression levels of Rnd3 in the human heart and detected significant downregulation of Rnd3 in patients with end-stage heart failure. We concluded that Rnd3 acted as a novel proangiogenic factor involved in cardiac responsive angiogenesis through HIF1α-VEGFA signaling promotion. Rnd3 downregulation observed in patients with heart failure may explain the insufficient compensatory angiogenesis involved in the transition to heart failure.

Original languageEnglish (US)
Pages (from-to)597-605
Number of pages9
JournalHypertension
Volume67
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Hypoxia-Inducible Factor 1
Vascular Endothelial Growth Factor A
Heart Failure
Down-Regulation
rho GTP-Binding Proteins
Monomeric GTP-Binding Proteins
Dilated Cardiomyopathy
Constriction
Knockout Mice
Transgenic Mice
Endothelial Cells
Hypertension
Phenotype
Pressure

Keywords

  • angiogenesis factor
  • G-protein
  • heart failure
  • hypertension
  • hypertrophy
  • vascular endothelial growth factor A

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Rnd3/RhoE Modulates Hypoxia-Inducible Factor 1α/Vascular Endothelial Growth Factor Signaling by Stabilizing Hypoxia-Inducible Factor 1α and Regulates Responsive Cardiac Angiogenesis. / Yue, Xiaojing; Lin, Xi; Yang, Tingli; Yang, Xiangsheng; Yi, Xin; Jiang, Xuejun; Li, Xiaoyan; Li, Tianfa; Guo, Junli; Dai, Yuan; Shi, Jianjian; Wei, Lei; Youker, Keith A.; Torre-Amione, Guillermo; Yu, Yanhong; Andrade, Kelsey C.; Chang, Jiang.

In: Hypertension, Vol. 67, No. 3, 01.03.2016, p. 597-605.

Research output: Contribution to journalArticle

Yue, X, Lin, X, Yang, T, Yang, X, Yi, X, Jiang, X, Li, X, Li, T, Guo, J, Dai, Y, Shi, J, Wei, L, Youker, KA, Torre-Amione, G, Yu, Y, Andrade, KC & Chang, J 2016, 'Rnd3/RhoE Modulates Hypoxia-Inducible Factor 1α/Vascular Endothelial Growth Factor Signaling by Stabilizing Hypoxia-Inducible Factor 1α and Regulates Responsive Cardiac Angiogenesis', Hypertension, vol. 67, no. 3, pp. 597-605. https://doi.org/10.1161/HYPERTENSIONAHA.115.06412
Yue, Xiaojing ; Lin, Xi ; Yang, Tingli ; Yang, Xiangsheng ; Yi, Xin ; Jiang, Xuejun ; Li, Xiaoyan ; Li, Tianfa ; Guo, Junli ; Dai, Yuan ; Shi, Jianjian ; Wei, Lei ; Youker, Keith A. ; Torre-Amione, Guillermo ; Yu, Yanhong ; Andrade, Kelsey C. ; Chang, Jiang. / Rnd3/RhoE Modulates Hypoxia-Inducible Factor 1α/Vascular Endothelial Growth Factor Signaling by Stabilizing Hypoxia-Inducible Factor 1α and Regulates Responsive Cardiac Angiogenesis. In: Hypertension. 2016 ; Vol. 67, No. 3. pp. 597-605.
@article{fc76cc88fba548c6b6fe570d73c5ab43,
title = "Rnd3/RhoE Modulates Hypoxia-Inducible Factor 1α/Vascular Endothelial Growth Factor Signaling by Stabilizing Hypoxia-Inducible Factor 1α and Regulates Responsive Cardiac Angiogenesis",
abstract = "The insufficiency of compensatory angiogenesis in the heart of patients with hypertension contributes to heart failure transition. The hypoxia-inducible factor 1α-vascular endothelial growth factor (HIF1α-VEGF) signaling cascade controls responsive angiogenesis. One of the challenges in reprograming the insufficient angiogenesis is to achieve a sustainable tissue exposure to the proangiogenic factors, such as HIF1α stabilization. In this study, we identified Rnd3, a small Rho GTPase, as a proangiogenic factor participating in the regulation of the HIF1α-VEGF signaling cascade. Rnd3 physically interacted with and stabilized HIF1α, and consequently promoted VEGFA expression and endothelial cell tube formation. To demonstrate this proangiogenic role of Rnd3 in vivo, we generated Rnd3 knockout mice. Rnd3 haploinsufficient (Rnd3+/-) mice were viable, yet developed dilated cardiomyopathy with heart failure after transverse aortic constriction stress. The poststress Rnd3+/- hearts showed significantly impaired angiogenesis and decreased HIF1α and VEGFA expression. The angiogenesis defect and heart failure phenotype were partially rescued by cobalt chloride treatment, a HIF1α stabilizer, confirming a critical role of Rnd3 in stress-responsive angiogenesis. Furthermore, we generated Rnd3 transgenic mice and demonstrated that Rnd3 overexpression in heart had a cardioprotective effect through reserved cardiac function and preserved responsive angiogenesis after pressure overload. Finally, we assessed the expression levels of Rnd3 in the human heart and detected significant downregulation of Rnd3 in patients with end-stage heart failure. We concluded that Rnd3 acted as a novel proangiogenic factor involved in cardiac responsive angiogenesis through HIF1α-VEGFA signaling promotion. Rnd3 downregulation observed in patients with heart failure may explain the insufficient compensatory angiogenesis involved in the transition to heart failure.",
keywords = "angiogenesis factor, G-protein, heart failure, hypertension, hypertrophy, vascular endothelial growth factor A",
author = "Xiaojing Yue and Xi Lin and Tingli Yang and Xiangsheng Yang and Xin Yi and Xuejun Jiang and Xiaoyan Li and Tianfa Li and Junli Guo and Yuan Dai and Jianjian Shi and Lei Wei and Youker, {Keith A.} and Guillermo Torre-Amione and Yanhong Yu and Andrade, {Kelsey C.} and Jiang Chang",
year = "2016",
month = "3",
day = "1",
doi = "10.1161/HYPERTENSIONAHA.115.06412",
language = "English (US)",
volume = "67",
pages = "597--605",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Rnd3/RhoE Modulates Hypoxia-Inducible Factor 1α/Vascular Endothelial Growth Factor Signaling by Stabilizing Hypoxia-Inducible Factor 1α and Regulates Responsive Cardiac Angiogenesis

AU - Yue, Xiaojing

AU - Lin, Xi

AU - Yang, Tingli

AU - Yang, Xiangsheng

AU - Yi, Xin

AU - Jiang, Xuejun

AU - Li, Xiaoyan

AU - Li, Tianfa

AU - Guo, Junli

AU - Dai, Yuan

AU - Shi, Jianjian

AU - Wei, Lei

AU - Youker, Keith A.

AU - Torre-Amione, Guillermo

AU - Yu, Yanhong

AU - Andrade, Kelsey C.

AU - Chang, Jiang

PY - 2016/3/1

Y1 - 2016/3/1

N2 - The insufficiency of compensatory angiogenesis in the heart of patients with hypertension contributes to heart failure transition. The hypoxia-inducible factor 1α-vascular endothelial growth factor (HIF1α-VEGF) signaling cascade controls responsive angiogenesis. One of the challenges in reprograming the insufficient angiogenesis is to achieve a sustainable tissue exposure to the proangiogenic factors, such as HIF1α stabilization. In this study, we identified Rnd3, a small Rho GTPase, as a proangiogenic factor participating in the regulation of the HIF1α-VEGF signaling cascade. Rnd3 physically interacted with and stabilized HIF1α, and consequently promoted VEGFA expression and endothelial cell tube formation. To demonstrate this proangiogenic role of Rnd3 in vivo, we generated Rnd3 knockout mice. Rnd3 haploinsufficient (Rnd3+/-) mice were viable, yet developed dilated cardiomyopathy with heart failure after transverse aortic constriction stress. The poststress Rnd3+/- hearts showed significantly impaired angiogenesis and decreased HIF1α and VEGFA expression. The angiogenesis defect and heart failure phenotype were partially rescued by cobalt chloride treatment, a HIF1α stabilizer, confirming a critical role of Rnd3 in stress-responsive angiogenesis. Furthermore, we generated Rnd3 transgenic mice and demonstrated that Rnd3 overexpression in heart had a cardioprotective effect through reserved cardiac function and preserved responsive angiogenesis after pressure overload. Finally, we assessed the expression levels of Rnd3 in the human heart and detected significant downregulation of Rnd3 in patients with end-stage heart failure. We concluded that Rnd3 acted as a novel proangiogenic factor involved in cardiac responsive angiogenesis through HIF1α-VEGFA signaling promotion. Rnd3 downregulation observed in patients with heart failure may explain the insufficient compensatory angiogenesis involved in the transition to heart failure.

AB - The insufficiency of compensatory angiogenesis in the heart of patients with hypertension contributes to heart failure transition. The hypoxia-inducible factor 1α-vascular endothelial growth factor (HIF1α-VEGF) signaling cascade controls responsive angiogenesis. One of the challenges in reprograming the insufficient angiogenesis is to achieve a sustainable tissue exposure to the proangiogenic factors, such as HIF1α stabilization. In this study, we identified Rnd3, a small Rho GTPase, as a proangiogenic factor participating in the regulation of the HIF1α-VEGF signaling cascade. Rnd3 physically interacted with and stabilized HIF1α, and consequently promoted VEGFA expression and endothelial cell tube formation. To demonstrate this proangiogenic role of Rnd3 in vivo, we generated Rnd3 knockout mice. Rnd3 haploinsufficient (Rnd3+/-) mice were viable, yet developed dilated cardiomyopathy with heart failure after transverse aortic constriction stress. The poststress Rnd3+/- hearts showed significantly impaired angiogenesis and decreased HIF1α and VEGFA expression. The angiogenesis defect and heart failure phenotype were partially rescued by cobalt chloride treatment, a HIF1α stabilizer, confirming a critical role of Rnd3 in stress-responsive angiogenesis. Furthermore, we generated Rnd3 transgenic mice and demonstrated that Rnd3 overexpression in heart had a cardioprotective effect through reserved cardiac function and preserved responsive angiogenesis after pressure overload. Finally, we assessed the expression levels of Rnd3 in the human heart and detected significant downregulation of Rnd3 in patients with end-stage heart failure. We concluded that Rnd3 acted as a novel proangiogenic factor involved in cardiac responsive angiogenesis through HIF1α-VEGFA signaling promotion. Rnd3 downregulation observed in patients with heart failure may explain the insufficient compensatory angiogenesis involved in the transition to heart failure.

KW - angiogenesis factor

KW - G-protein

KW - heart failure

KW - hypertension

KW - hypertrophy

KW - vascular endothelial growth factor A

UR - http://www.scopus.com/inward/record.url?scp=84958042734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958042734&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.115.06412

DO - 10.1161/HYPERTENSIONAHA.115.06412

M3 - Article

C2 - 26781283

AN - SCOPUS:84958042734

VL - 67

SP - 597

EP - 605

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 3

ER -